These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11513478)

  • 1. Nitric oxide synthase inhibition by L-NAME prevents the decrease of Na+,K+-ATPase activity in midbrain of rats subjected to arginine administration.
    Wyse AT; Bavaresco CS; Bandinelli C; Streck EL; Franzon R; Dutra-Filho CS; Wajner M
    Neurochem Res; 2001 May; 26(5):515-20. PubMed ID: 11513478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arginine administration inhibits hippocampal Na(+),K(+)-ATPase activity and impairs retention of an inhibitory avoidance task in rats.
    dos Reis EA; de Oliveira LS; Lamers ML; Netto CA; Wyse AT
    Brain Res; 2002 Oct; 951(2):151-7. PubMed ID: 12270492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of nitric oxide synthesis inhibition on the Na,K-ATPase activity in the kidney.
    Kang DG; Kim JW; Lee J
    Pharmacol Res; 2000 Jan; 41(1):123-7. PubMed ID: 10600280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of nitric oxide synthase inhibition or antioxidants on brain oxidative damage caused by intracerebroventricular arginine administration.
    Delwing D; Delwing D; Bavaresco CS; Wyse AT
    Brain Res; 2008 Feb; 1193():120-7. PubMed ID: 18190896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of L-arginine on Na+,K+-ATPase activity in rat aorta endothelium.
    Akopova OV; Kharlamova ON; Vavilova GL
    Biochemistry (Mosc); 2002 Sep; 67(9):1058-61. PubMed ID: 12387723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclooxygenase pathway is involved in the vascular reactivity and inhibition of the Na+, K+-ATPase activity in the tail artery from L-NAME-treated rats.
    dos Santos L; Xavier FE; Vassallo DV; Rossoni LV
    Life Sci; 2003 Dec; 74(5):613-27. PubMed ID: 14623032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of CO(2) production from glucose by arginine in brain slices of rats.
    Delwing D; Stefanello FM; Perry ML; Wyse AT
    Metab Brain Dis; 2007 Jun; 22(2):145-55. PubMed ID: 17516157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain Na+,K(+)-ATPase inhibition induced by arginine administration is prevented by vitamins E and C.
    Bavaresco CS; Calcagnotto T; Tagliari B; Delwing D; Lamers ML; Wannmacher CM; Wajner M; Wyse AT
    Neurochem Res; 2003 Jun; 28(6):825-9. PubMed ID: 12718434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of L-nitroarginine to inhibit the activity of aortic inducible nitric oxide synthase.
    Darblade B; Batkai S; Caussé E; Gourdy P; Fouque MJ; Rami J; Arnal JF
    J Vasc Res; 2001; 38(3):266-75. PubMed ID: 11399899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional alterations of cardiac (Na,K)-ATPase in L-NAME induced hypertension.
    Vrbjar N; Bernátová I; Pechánová O
    Gen Physiol Biophys; 1999 Dec; 18 Suppl 1():10-2. PubMed ID: 10707824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes of sodium and ATP affinities of the renal Na,K-ATPase during and after nitric oxide-deficient hypertension.
    Vrbjar N; Javorková V; Pechánová O
    Physiol Res; 2002; 51(5):475-81. PubMed ID: 12470200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arginine administration reduces catalase activity in midbrain of rats.
    Delwing D; Delwing D; Dutra-Filho CS; Wannmacher CM; Wajner M; Wyse AT
    Neuroreport; 2002 Jul; 13(10):1301-4. PubMed ID: 12151791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of energy metabolism in rat hippocampus by arginine administration.
    Delwing D; Tagliari B; Streck EL; Wannamacher CM; Wajner M; Wyse AT
    Brain Res; 2003 Sep; 983(1-2):58-63. PubMed ID: 12914966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of maturation on renal Na+/K+-atpase and its susceptibility to nitric oxide-deficient hypertension in rats.
    Javorková V; Vlkovicova J; Kunes J; Pechanova O; Zicha J; Vrbjar N
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):617-23. PubMed ID: 17581218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain cell membrane Na+,K(+)-ATPase activity after inhibition of cerebral nitric oxide synthase by intravenous NG-nitro-L-arginine in newborn piglets.
    Groenendaal F; Mishra OP; McGowan JE; Delivoria-Papadopoulos M
    Biol Neonate; 1995; 68(6):419-25. PubMed ID: 8721886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term NO synthase inhibition and the Na+-binding properties of cardiac Na,K-ATPase.
    Vrbjar N; Strnisková M; Pechánová O; Gerová M
    Physiol Res; 2000; 49(1):65-70. PubMed ID: 10805406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interactive contributions of Na(+) /K(+) -ATPase and nitric oxide synthase to sweating and cutaneous vasodilatation during exercise in the heat.
    Louie JC; Fujii N; Meade RD; Kenny GP
    J Physiol; 2016 Jun; 594(12):3453-62. PubMed ID: 26852741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NO donors inhibit Na,K-ATPase activity by a protein kinase G-dependent mechanism in the nonpigmented ciliary epithelium of the porcine eye.
    Shahidullah M; Delamere NA
    Br J Pharmacol; 2006 Jul; 148(6):871-80. PubMed ID: 16770322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic nitric oxide synthase inhibition exacerbates renal dysfunction in cirrhotic rats.
    Graebe M; Brond L; Christensen S; Nielsen S; Olsen NV; Jonassen TE
    Am J Physiol Renal Physiol; 2004 Feb; 286(2):F288-97. PubMed ID: 14583432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective nitric oxide production impairs angiotensin II-induced Na-K-ATPase regulation in spontaneously hypertensive rats.
    Javkhedkar AA; Lokhandwala MF; Banday AA
    Am J Physiol Renal Physiol; 2012 Jan; 302(1):F47-51. PubMed ID: 21900450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.